| abstract |
The present invention describes modulators of Aβ secretion that were not previously known. These proteins are identified as suitable targets for the development of new therapies for treating, preventing or alleviating pathological conditions associated with Aβ secretion, including Alzheimer's disease. The present invention also relates to a pharmaceutical composition comprising a method for treating, preventing or alleviating said pathological condition, and therefore a modulator having an inhibitory effect on the activity and / or expression of these modulators. Related. |